Last reviewed · How we verify

NCT04119180

Sedation Versus Protective Stabilization for Pediatric Dental Treatment

Recruiting now Phase 4 Last updated 10 December 2024
What this trial tests

Phase 4 trial testing Ketamine 50 MG/ML in Child Behavior in 152 participants. Currently enrolling.

Timeline
30 January 2020
Primary endpoint
28 February 2025
28 February 2026

Quick facts

Lead sponsorUniversidade Federal de Goias
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment152
Start date30 January 2020
Primary completion28 February 2025
Estimated completion28 February 2026
Sites2 locations across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Federal de Goias — full company profile →

Who can join

Adults 1 to 7, any sex, with Child Behavior or Dental Caries in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is a lack of evidence on the effectiveness of moderate sedation in pediatric dentistry, compared to protective stabilization, which remains routinely used in the Brazilian context despite moral questions. The objective of this prospective nonrandomized clinical trial is to evaluate the effectiveness of the use of moderate sedation, compared to the protective stabilization, in the dental care of children with fear / anxiety and / or dental behavior problem, and associated factors. The study will be carried out in outpatient clinics of the Dental Schools of the Federal University of Goiás (UFG) and University of São Paulo (USP), with the support of professors from King's College London through the partnership CEDACORE - Children Experiencing Dental Anxiety: Collaboration on Research and Education. Participants will be 152 children under 7 years of age with dental caries, who need specialized dental treatment due to a history of non-cooperation with dental care. The interventions to be compared are moderate sedation with oral administration of ketamine and midazolam (UFG) and protective stabilization (USP). The primary endpoint 'behavior / anxiety of the child during treatment will be assessed using the Ohio State University Behavioral Rating Scale. The secondary outcomes are: dental behavioral and anxiety evolution of the child, child' pain during procedure, impact on the quality of life related to oral health, parents and dentists' satisfaction and stress, adverse events for sedated participants, longevity of composite and glass ionomer cement restorations, chronotype and physiological stress of these children. A cost-efficacy analysis will be produced at the end of the study from the perspective of the Sistema Único de Saúde. Additionally, at the end of 36 months, the investigators expect to contribute to the identification of psychosocial aspects related to dental behavior problems in children in early childhood. It is important to highlight the perspective of technological innovation, with the creation of a digital platform that will allow the registration of data related to the dental care of children worldwide and favor analyzes in the methodology of data science.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Sedation versus protective stabilization for dental treatment of children with caries and challenging behavior at the dentist (CHOOSE): a study protocol for a non-randomized clinical trial.
    da Silva GS, Anabuki AA, Viana KA, Corrêa-Faria P, et al · · 2021 · cited 5× · PMID 33980232 · DOI 10.1186/s12903-021-01594-0

Verify or expand the search:

Other trials of Ketamine 50 MG/ML

Trials testing the same drug.

Other recruiting trials for Child Behavior

Currently open trials in the same condition.

Other Universidade Federal de Goias trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04119180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing